What happened
Varex Imaging (NASDAQ: VREX) stock trailed the market last month by shedding 17% compared to a 2% decline in the S&P 500, according to S&P Global Market Intelligence. The drop has pushed shares to single-digit returns so far in 2019, although the stock rebounded to more solidly positive territory in early September.
Image source: Getty Images.
So what
August's slump was driven by the mixed fiscal second-quarter results that Varex issued on Aug. 6. The medical device specialist noted healthy demand in several markets including oncology and mammography imaging but saw a sharp drop-off in radiographic detectors. Overall, sales inched higher by 3% to $197 million. Adjusted profitability worsened slightly, falling to 34% of sales from 35% a year earlier.
Now what
CEO Sunny Sanyal said at the time that the latest results keep the company on pace to reach its broader 2019 sales goals, which involve revenue ranging from $760 million to $785 million compared to $773 million in 2018. Yet the small-cap stock is likely to remain volatile while sales growth is muted and while Varex implements its restructuring program through mid-2020.
10 stocks we like better than Varex Imaging
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Varex Imaging wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 1, 2019
Demitrios Kalogeropoulos has no position in any of the stocks mentioned. The Motley Fool owns shares of Varex Imaging. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
